Imbruvica and Death - a phase IV clinical study of FDA data
Death is found among people who take Imbruvica, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study is created by eHealthMe based on reports of 50,071 people who have side effects when taking Imbruvica from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
50,071 people reported to have side effects when taking Imbruvica.
Among them, 5,356 people (10.7%) died.
What is Imbruvica?
Imbruvica has active ingredients of ibrutinib. It is often used in chronic lymphocytic leukemia (cll). eHealthMe is studying from 50,138 Imbruvica users for its effectiveness, alternative drugs and more.
Number of Imbruvica and Death reports submitted per year:
Time on Imbruvica when people died *:
Gender of people who died when taking Imbruvica*:
Age of people who died when taking Imbruvica *:
Common drugs people take besides Imbruvica *:
Common side effects people have before they died *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Expand to all the drugs that have ingredients of ibrutinib:
- Death and drugs with ingredients of ibrutinib (5,791 reports)
Alternative drugs to, pros and cons of Imbruvica:
- Imbruvica (50,138 reports)
Common Imbruvica side effects:
- Death: 5,356 reports
- Fatigue (feeling of tiredness): 4,151 reports
- Diarrhea: 3,399 reports
- Head injury: 2,818 reports
- Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2,600 reports
- Pneumonia: 2,428 reports
- Weakness: 2,420 reports
- Rashes (redness): 2,329 reports
Browse all side effects of Imbruvica:a b c d e f g h i j k l m n o p q r s t u v w x y z
COVID vaccines that are related to Death:
- Death in Moderna COVID Vaccine
- Death in Pfizer BioNTech Covid Vaccine
- Death in Johnson and Johnson Covid Vaccine
Common drugs associated with Death:
- Oxycontin: 25,919 reports
- Revlimid: 24,344 reports
- Duragesic: 15,960 reports
- Dilaudid: 15,851 reports
- Percocet: 15,739 reports
- Prolia: 14,914 reports
- Ms contin: 14,867 reports
- Aranesp: 14,840 reports
- Aspirin: 14,746 reports
- Opana: 13,795 reports
All the drugs that are associated with Death:
- Death (4,468 drugs)
Common conditions associated with Death:
- Multiple myeloma: 23,142 reports
- Pain: 20,012 reports
- Primary pulmonary hypertension: 17,771 reports
All the conditions that are associated with Death:
- Death (3,693 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ibrutinib (the active ingredients of Imbruvica) and Imbruvica (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Letrozole and Red Blood Cell Count Decreased - a second ago
- Chloramphenicol and Sleep Apnea Syndrome - a second ago
- Zyrtec and Lisinopril drug interaction - 17 seconds ago
- Blood Corticotrophin Increased and Weakness - 30 seconds ago
- Gleevec and Paraplegia - 32 seconds ago
- Prilosec and Haemorrhage Intracranial - 37 seconds ago
- Buprenorphine and Intestinal Obstruction - 37 seconds ago
- Buprenorphine and Facial Paralysis - 38 seconds ago
- Amoxicillin And Clavulanate Potassium and Renal Artery Stenosis - 43 seconds ago
- Ketek and Faeces Discolored - 46 seconds ago